Access to anti-retroviral drugs, female in Singapore
Singapore: Access to anti-retroviral drugs, female was 84.0% in 2023. ◆ Volatile
Access to anti-retroviral drugs, female in Singapore, 2000–2023
Source: UNAIDS estimates. Measured in %.
Analysis
Singapore recorded 84.0% for access to anti-retroviral drugs, female in 2023. That is the highest value across all 24 years on record.
That represents a change of up 6.3% on the previous year and up 37.7% over ten years.
Over the whole period, access to anti-retroviral drugs, female in Singapore peaked at 84.0% in 2023 and was at its lowest, 5.0%, in 2000.
That places Singapore 50th out of 141 countries with data for 2023, putting it in the middle of the range.
The series is highly variable year to year, so single readings are best treated with caution.
Access to anti-retroviral drugs, female in Singapore, year by year
| Year | % | Change |
|---|---|---|
| 2000 | 5.0% | — |
| 2001 | 6.0% | +20.0% |
| 2002 | 8.0% | +33.3% |
| 2003 | 9.0% | +12.5% |
| 2004 | 10.0% | +11.1% |
| 2005 | 15.0% | +50.0% |
| 2006 | 23.0% | +53.3% |
| 2007 | 31.0% | +34.8% |
| 2008 | 41.0% | +32.3% |
| 2009 | 51.0% | +24.4% |
| 2010 | 32.0% | -37.3% |
| 2011 | 35.0% | +9.4% |
| 2012 | 41.0% | +17.1% |
| 2013 | 61.0% | +48.8% |
| 2014 | 61.0% | +0.0% |
| 2015 | 71.0% | +16.4% |
| 2016 | 72.0% | +1.4% |
| 2017 | 72.0% | +0.0% |
| 2018 | 73.0% | +1.4% |
| 2019 | 78.0% | +6.8% |
| 2020 | 82.0% | +5.1% |
| 2021 | 78.0% | -4.9% |
| 2022 | 79.0% | +1.3% |
| 2023 | 84.0% | +6.3% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 19.9% | 5.0% | 51.0% | 10 |
| 2010s | 59.6% | 32.0% | 78.0% | 10 |
| 2020s | 80.8% | 78.0% | 84.0% | 4 |
Countries ranked near Singapore
More gender data for Singapore
- Child population (UN estimates and projections) 724.18 (2030)
- Child population (UN estimates and projections) (0-14), annual growth 0.914 % change on previous year (2030)
- Population 5,307 (2030)
- Working-age population (UN estimates and projections) 5,307 (2030)
- Population (UN estimates and projections), annual growth rate 0.3921 % change on previous year (2030)
- Age population, age 00, female, interpolated 23,989 (2025)
- Age population, age 00, male, interpolated 25,420 (2025)
- Age population, age 01, female, interpolated 23,551 (2025)
- Age population, age 01, male, interpolated 24,949 (2025)
- Age population, age 02, female, interpolated 22,853 (2025)
Frequently asked questions
- What is access to anti-retroviral drugs, female in Singapore?
- Access to anti-retroviral drugs, female in Singapore was 84.0% in 2023, according to UNAIDS estimates.
- What is the highest access to anti-retroviral drugs, female recorded in Singapore?
- The highest recorded value was 84.0% in 2023.
- What is the lowest access to anti-retroviral drugs, female recorded in Singapore?
- The lowest recorded value was 5.0% in 2000.
- How does Singapore rank for access to anti-retroviral drugs, female?
- Singapore ranks 50th out of 141 countries with data for 2023.
- Is access to anti-retroviral drugs, female rising or falling in Singapore?
- Over the last ten years it is up 37.7%. The long-run trend across the full record is volatile.
- Where does this Singapore data come from?
- The figures come from UNAIDS estimates, published as part of Access to anti-retroviral drugs, female (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 24 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.